Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells - 02/09/11
Abstract |
Background: UVA1 radiation seems to be effective in morphea. CD34+ dendritic cells are significantly decreased in lesional skin of morphea patients. Objective: We evaluated the therapeutic effectiveness of medium-dose UVA1 phototherapy in localized scleroderma and its effect in the number of dermal CD34+ dendritic cells in skin biopsy specimens of these patients. Method: Patients were irradiated with UVA1 (30 J/cm2) 30 times. Dermal CD34+ dendritic cells were counted before and after therapy. Results: There was clinical improvement after UVA1 irradiation. Dermal CD3 4+ dendritic cells significantly increased after UVA1 irradiation. Conclusion: Medium-dose UVA1 therapy is effective in the treatment of localized morphea. Effectiveness is associated with an increase in the number of CD34+ dendritic cells in the dermis. (J Am Acad Dermatol 2001;45:697-9.)
Le texte complet de cet article est disponible en PDF.
Vol 45 - N° 5
P. 697-699 - novembre 2001 Retour au numéro
Article précédent
- Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: A distinct direct immunofluorescence trend revealed by the literature
- Richard W. Plunkett, Stephen E. Chiarello, Ernst H. Beutner
- A modified staging classification for cutaneous T-cell lymphoma
- Mohammed Kashani-Sabet, Alex McMillan, Herschel S. Zackheim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?